Sort
39,280 grants matching “leukemia”
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$620,436Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
$620,251Dong-Er Zhang · University Of California, San Diego · R01 · FY2022 · DK
The Molecular Pathology of Myeloproliferative Disease
$620,250Mount Sinai School Of Medicine Of Nyu · R01 · FY2005 · HL
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
$620,114Ehab L Atallah · Medical College Of Wisconsin · R01 · FY2018 · CA
Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance
$620,109Neil P Shah · University Of California, San Francisco · R01 · FY2024 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$620,011Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Retrovirus Assembly and Maturation
$619,902Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Single Cell Methods for Bioeffector Discovery and Analysis
$619,847Brian O Bachmann · Vanderbilt University · R01 · FY2019 · CA
INTERROGATION OF REQUISITE NICHE FACTORS FOR LEUKEMIA CELL SURVIVAL AT SINGLE-CELL RESOLUTION
$619,846Massachusetts Institute Of Technology · · FY2021 · Department of the Army
Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer
$619,814Alejandro Gutierrez · Boston Children'S Hospital · R01 · FY2023 · CA
Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy
$619,765A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Altered RNA fates due to an MDS driver mutation in SF3B1
$619,750Manoj M. Pillai · Yale University · R01 · FY2024 · HL
Targeting B7-H3 in ovarian cancer
$619,664Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Structural studies of viral replication and invasion
$619,646Hideki Aihara · University Of Minnesota · R35 · FY2024 · GM
Structural studies of viral replication and invasion
$619,646Hideki Aihara · University Of Minnesota · R35 · FY2023 · GM
Structural studies of viral replication and invasion
$619,646Hideki Aihara · University Of Minnesota · R35 · FY2022 · GM
Structural studies of viral replication and invasion
$619,646Hideki Aihara · University Of Minnesota · R35 · FY2025 · GM
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$619,470Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines
$619,433Saad J. Kenderian · Mayo Clinic Rochester · R37 · FY2023 · CA
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
$619,360Frederic D Bushman · University Of Pennsylvania · R01 · FY2020 · CA
Apolipoprotein M: a novel regulator of myocardial Autophagy
$619,115Ali Javaheri · Washington University · R01 · FY2022 · HL
Studies of Proteins with Important Roles in Immunology andor Cancer Biology
$619,065Jacek T Lubkowski · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
DNA Sequencing and Digital Gene Expression Core
$619,049Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
$619,047Jun J. Yang · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
An Integrative Approach to Evaluate Neurocognitive Disparities in Latinos Undergoing Treatment for Childhood Leukemia.
$619,041Kimberly Pauline Raghubar · Baylor College Of Medicine · R01 · FY2022 · CA